Results 201 to 210 of about 119,881 (373)

DIAGNOSTIC CONCORDANCE AMONG PATHOLOGISTS INTERPRETING ORAL MUCOSAL BIOPSIES FROM INDIVIDUALS AFFECTED BY GVHD

, 2019
Prof. Fabio Coracin, Prof. Paulo Sergio Da Silva Santos, P.S. Sousa, Prof. Fabiana Martins, Prof. Washington Steagall, Prof. Marina Gallottini   +5 more
openalex   +1 more source

CCR2 Orchestrates Preferential Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Rheumatoid Arthritis

MedComm, Volume 7, Issue 1, January 2026.
CCR2 orchestrates preferential homing of GMSC‐derived extracellularvesicles to inflamed joints in rheumatoid arthritis. ABSTRACT The clinical utility of mesenchymal stem cells (MSCs) is often limited by pulmonary entrapment and poor systemic distribution, particularly in diseases constrained by physiological barriers such as rheumatoid arthritis (RA ...
Jingrong Chen, Xiao Guan, Wenbin Wu, Luyao Wu, Yan Liu, Donglan Zeng, Junlong Dang, Jun Zhao, Julie Wang, Jia Yuan, Xiaoli Fan, Yunfeng Pan, Nancy Olsen, Song Guo Zheng   +13 more
wiley   +1 more source

Improved survival after acute graft-versus-host disease diagnosis in the modern era [PDF]

, 2017
et al.,, Hayashi, Robert J, Vig, Ravi
core   +1 more source

The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of GVHD in Children

, 2013
Hemalatha G. Rangarajan, Rowena C. Punzalan, Julie‐An Talano   +2 more
openalex   +1 more source

Assessing Recurrent Acute Rhinosinusitis Development in Posttransplant Patients: A Study on Sinus Surgery Necessity

OTO Open, Volume 10, Issue 1, January-March 2026.
Abstract Objective Recurrent acute rhinosinusitis (RARS) significantly decreases quality of life. Transplant recipients (TR) are particularly vulnerable to rhinologic conditions. There is a lack of guidelines for managing RARS in this population. Our study aims to determine the prevalence of and risk factors for RARS among TR and assess the need for ...
Estephania Candelo, Anyull Dayanna Bohorquez‐Caballero, Angela M. Donaldson   +2 more
wiley   +1 more source

GVHD and prognostic factors [PDF]

American Journal of Hematology, 2006
BONIFAZI, FRANCESCA, BANDINI, GIUSEPPE, Giovannini M, Falcioni S, BACCARANI, MICHELE   +4 more
openaire   +1 more source

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

Bone Marrow Transplantation, 2016
A. Ruggeri, M. Labopin, F. Ciceri, M. Mohty, A. Nagler, A. Nagler   +5 more
semanticscholar   +1 more source

DNA‐Loaded Nanoparticles Reprogram the Tumor Immune Microenvironment to Treat Brain Tumors

Small Science, Volume 6, Issue 1, January 2026.
Biodegradable poly(beta‐amino ester) nanoparticles can be employed to deliver immunostimulatory genes (4‐1BBL and IL‐12) to reprogram brain tumor cells into antigen‐presenting cells to stimulate an anti‐tumor response, resulting in tumor regression and long‐term survival in GBM and meningioma models.
Joanna Yang, Divyaansh Raj, Hasan Slika, Aanya Shahani, Leonardo Cheng, Manav Jain, Ethan Idnani, Kathryn M. Luly, FNU Ruchika, Caitlin Kraft, Charles Eberhart, Henry Brem, Betty Tyler, Jordan J. Green, Stephany Y. Tzeng   +14 more
wiley   +1 more source

Advancing Knowledge of Acute Cutaneous Graft-Versus-Host Disease Wound Care: A Case Study. [PDF]

J Wound Ostomy Continence Nurs
Errichiello S, Visintini C, Rosignoli C, Cerne D, Petruzzellis G, Patriarca F, Palese A.   +6 more
europepmc   +1 more source

Multivisceral allotransplantation in pigs [PDF]

, 1996
Furukawa, H, Nakamura, K, Starzl, TE, Todo, S, Zhu, Y   +4 more
core